drugset / Trial / NCT00092846

A 6-Month Consumer Behavior Study of a Self-Management System (0803-084)(COMPLETED)

NCT00092846

Phase 3 Completed 1000 enrolled Merck Sharp & Dohme LLC
Non-randomizedSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to evaluate the ability of patients with intermediate risk of heart disease to appropriately use a Self-Management System.

Timeline

Start
2002-12-04
Primary completion
2003-09-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Lovastatin Small molecule

Indications